Board of Directors

The CMPI Board of Directors is comprised of some of the nation’s leaders in academic medical research, clinical practice, health care delivery, patient advocacy, innovation leadership and science reporting. The board will be involved in helping CMPI reaching a broader group of stakeholders in their respective communities and in shaping CMPI programs in the future.

Gad Berdugo
General Partner,
Explorium Capital LLC

Fred Goodwin, M.D.
Professor of Psychiatry,
The George Washington University Medical Center.

Steven Sammut
Lecturer,
Wharton School, the Law School and the School of Engineering and Applied Science of the University of Pennsylvania

Michael Tew
Principal
SandHill RP

Mark Thornton, M.D., Ph.D.
Chairman and President,
Sarcoma Foundation of America

Michael Weber, M.D.
Professor of Medicine,
SUNY Downstate College of Medicine
Brooklyn, New York
Sign Up for Our Email Newsletter

RECENT NEWS

Health sharing, a viable option for health care

Health sharing, a viable option for health care

One of the key lessons we’ve learned from the Obamacare experience is that “having health insurance” isn’t the same thing...  Read more

Zeroing Out Drug Prices

Zeroing Out Drug Prices

There are some tough but important basic principles when it comes to innovation in health care technologies....  Read more

Elizabeth Warren's Threat to Medical Progress

Elizabeth Warren's Threat to Medical Progress

Senator Elizabeth Warren (D-MA) mistakenly believes that pharmaceutical innovation is primarily driven by the National In...  Read more

DRUGWONKS BLOG